| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 4.86e-08 | 22 | 93 | 5 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 7.79e-08 | 24 | 93 | 5 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 9.70e-08 | 25 | 93 | 5 | GO:0004114 | |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 9.78e-08 | 3 | 93 | 3 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 9.78e-08 | 3 | 93 | 3 | GO:0019118 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.46e-07 | 27 | 93 | 5 | GO:0004112 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 6.09e-06 | 97 | 93 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 1.57e-05 | 11 | 93 | 3 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 2.70e-05 | 13 | 93 | 3 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 2.70e-05 | 13 | 93 | 3 | GO:0016803 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.20e-05 | 39 | 93 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.43e-05 | 14 | 93 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | cGMP binding | 5.24e-05 | 16 | 93 | 3 | GO:0030553 | |
| GeneOntologyMolecularFunction | threonine-tRNA ligase activity | 6.42e-05 | 3 | 93 | 2 | GO:0004829 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 7.90e-05 | 386 | 93 | 9 | GO:0042578 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CYP1B1 PDE2A PRICKLE1 EXTL2 ADAMTS5 PPEF1 PIKFYVE TRIM67 PRICKLE3 TRIM9 AGMO PRICKLE2 ALAD PDZRN3 TARS1 DNMT1 | 1.12e-04 | 1189 | 93 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | O-methyltransferase activity | 2.09e-04 | 25 | 93 | 3 | GO:0008171 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.64e-04 | 27 | 93 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.40e-04 | 32 | 93 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | RNA 2'-O-methyltransferase activity | 7.56e-04 | 9 | 93 | 2 | GO:0062105 | |
| GeneOntologyMolecularFunction | zinc ion binding | PDE2A PRICKLE1 ADAMTS5 PIKFYVE TRIM67 PRICKLE3 TRIM9 PRICKLE2 ALAD PDZRN3 TARS1 DNMT1 | 8.67e-04 | 891 | 93 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | lipid kinase activity | 9.17e-04 | 41 | 93 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.15e-03 | 11 | 93 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 3.20e-03 | 213 | 93 | 5 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.97e-03 | 224 | 93 | 5 | GO:0016741 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 4.31e-03 | 807 | 93 | 10 | GO:0016788 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor-activated receptor activity | 3.71e-10 | 4 | 92 | 4 | GO:0031551 | |
| GeneOntologyBiologicalProcess | negative regulation of brain-derived neurotrophic factor receptor signaling pathway | 1.85e-09 | 5 | 92 | 4 | GO:0031549 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor receptor signaling pathway | 1.28e-08 | 7 | 92 | 4 | GO:0031548 | |
| GeneOntologyBiologicalProcess | negative regulation of signaling receptor activity | 3.40e-07 | 33 | 92 | 5 | GO:2000272 | |
| GeneOntologyBiologicalProcess | brain-derived neurotrophic factor receptor signaling pathway | 3.59e-07 | 14 | 92 | 4 | GO:0031547 | |
| GeneOntologyBiologicalProcess | negative regulation of protein tyrosine kinase activity | 9.29e-06 | 30 | 92 | 4 | GO:0061099 | |
| GeneOntologyBiologicalProcess | cAMP-mediated signaling | 2.28e-05 | 76 | 92 | 5 | GO:0019933 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 2.67e-05 | 131 | 92 | 6 | GO:0010469 | |
| GeneOntologyBiologicalProcess | positive regulation of oocyte development | 5.89e-05 | 3 | 92 | 2 | GO:0060282 | |
| GeneOntologyBiologicalProcess | threonyl-tRNA aminoacylation | 5.89e-05 | 3 | 92 | 2 | GO:0006435 | |
| GeneOntologyBiologicalProcess | phototransduction, visible light | 9.27e-05 | 20 | 92 | 3 | GO:0007603 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 1.08e-04 | 21 | 92 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | regulation of oocyte development | 1.17e-04 | 4 | 92 | 2 | GO:0060281 | |
| GeneOntologyBiologicalProcess | regulation of oogenesis | 1.17e-04 | 4 | 92 | 2 | GO:1905879 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-tyrosine phosphorylation | 1.40e-04 | 59 | 92 | 4 | GO:0050732 | |
| GeneOntologyBiologicalProcess | chronic inflammatory response | 1.84e-04 | 25 | 92 | 3 | GO:0002544 | |
| GeneOntologyBiologicalProcess | positive regulation of chronic inflammatory response | 1.95e-04 | 5 | 92 | 2 | GO:0002678 | |
| GeneOntologyBiologicalProcess | cGMP catabolic process | 1.95e-04 | 5 | 92 | 2 | GO:0046069 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 2.07e-04 | 26 | 92 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 2.07e-04 | 26 | 92 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 2.16e-04 | 272 | 92 | 7 | GO:0050730 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 2.32e-04 | 27 | 92 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | regulation of protein tyrosine kinase activity | 2.57e-04 | 69 | 92 | 4 | GO:0061097 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.87e-04 | 71 | 92 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | CYP1B1 FAM72D FAM72C KLRK1 FZD9 ADRB2 FAM72A PDE5A LTA FAM72B NSMAF | 3.49e-04 | 718 | 92 | 11 | GO:0043065 |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 4.07e-04 | 7 | 92 | 2 | GO:0071321 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | CYP1B1 FAM72D FAM72C KLRK1 FZD9 ADRB2 FAM72A PDE5A LTA FAM72B NSMAF | 4.45e-04 | 739 | 92 | 11 | GO:0043068 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.65e-04 | 34 | 92 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 4.65e-04 | 34 | 92 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 5.65e-04 | 229 | 92 | 6 | GO:0006643 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 6.53e-04 | 327 | 92 | 7 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 6.77e-04 | 329 | 92 | 7 | GO:0018212 | |
| GeneOntologyBiologicalProcess | response to cGMP | 6.94e-04 | 9 | 92 | 2 | GO:0070305 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 6.94e-04 | 9 | 92 | 2 | GO:0099562 | |
| MousePheno | abnormal somatic hypermutation frequency | 2.94e-06 | 19 | 76 | 4 | MP:0004815 | |
| MousePheno | increased B cell apoptosis | 1.50e-05 | 28 | 76 | 4 | MP:0008782 | |
| MousePheno | increased germinal center B cell number | 2.27e-05 | 31 | 76 | 4 | MP:0008177 | |
| MousePheno | abnormal class switch recombination | 7.72e-05 | 81 | 76 | 5 | MP:0004816 | |
| MousePheno | abnormal susceptibility to Herpesvirales infection | 8.67e-05 | 83 | 76 | 5 | MP:0020915 | |
| MousePheno | abnormal B cell apoptosis | 1.21e-04 | 47 | 76 | 4 | MP:0008781 | |
| MousePheno | abnormal B cell differentiation | 1.61e-04 | 287 | 76 | 8 | MP:0002144 | |
| MousePheno | abnormal Muller cell morphology | 1.65e-04 | 20 | 76 | 3 | MP:0005547 | |
| MousePheno | decreased neuron number | 1.94e-04 | 376 | 76 | 9 | MP:0008948 | |
| MousePheno | abnormal germinal center B cell number | 2.23e-04 | 55 | 76 | 4 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 2.23e-04 | 55 | 76 | 4 | MP:0008176 | |
| MousePheno | increased mature B cell number | 3.01e-04 | 168 | 76 | 6 | MP:0008210 | |
| Domain | FAM72 | 5.76e-10 | 4 | 93 | 4 | PF14976 | |
| Domain | FAM72 | 5.76e-10 | 4 | 93 | 4 | IPR026768 | |
| Domain | GAF | 1.99e-08 | 7 | 93 | 4 | PF01590 | |
| Domain | GAF | 3.97e-08 | 8 | 93 | 4 | IPR003018 | |
| Domain | GAF | 3.97e-08 | 8 | 93 | 4 | SM00065 | |
| Domain | PDEase_I | 5.25e-08 | 21 | 93 | 5 | PF00233 | |
| Domain | PDEASE_I | 5.25e-08 | 21 | 93 | 5 | PS00126 | |
| Domain | PDEase_CS | 5.25e-08 | 21 | 93 | 5 | IPR023174 | |
| Domain | - | 6.76e-08 | 22 | 93 | 5 | 1.10.1300.10 | |
| Domain | GAF_dom-like | 7.12e-08 | 9 | 93 | 4 | IPR029016 | |
| Domain | - | 7.12e-08 | 9 | 93 | 4 | 3.30.450.40 | |
| Domain | PDEase_catalytic_dom | 8.61e-08 | 23 | 93 | 5 | IPR002073 | |
| Domain | HDc | 1.08e-07 | 24 | 93 | 5 | SM00471 | |
| Domain | HD/PDEase_dom | 1.08e-07 | 24 | 93 | 5 | IPR003607 | |
| Domain | LIM3_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033727 | |
| Domain | LIM2_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033726 | |
| Domain | PET_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033723 | |
| Domain | PDEase | 2.11e-06 | 19 | 93 | 4 | IPR023088 | |
| Domain | PET | 2.36e-06 | 6 | 93 | 3 | PF06297 | |
| Domain | PET_domain | 2.36e-06 | 6 | 93 | 3 | IPR010442 | |
| Domain | PET | 2.36e-06 | 6 | 93 | 3 | PS51303 | |
| Domain | LIM1_prickle | 2.45e-05 | 2 | 93 | 2 | IPR033725 | |
| Domain | SV2 | 7.33e-05 | 3 | 93 | 2 | IPR022308 | |
| Domain | ThrRS_core | 7.33e-05 | 3 | 93 | 2 | IPR033728 | |
| Domain | Pentapeptide_4 | 7.33e-05 | 3 | 93 | 2 | PF13599 | |
| Domain | Thr-tRNA-ligase_IIa | 7.33e-05 | 3 | 93 | 2 | IPR002320 | |
| Domain | NADP_OxRdtase_dom | 7.73e-05 | 17 | 93 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 7.73e-05 | 17 | 93 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 7.73e-05 | 17 | 93 | 3 | IPR001395 | |
| Domain | 5peptide_repeat | 1.46e-04 | 4 | 93 | 2 | IPR001646 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 2.43e-04 | 5 | 93 | 2 | PS00707 | |
| Domain | TGS | 3.63e-04 | 6 | 93 | 2 | IPR004095 | |
| Domain | TGS | 3.63e-04 | 6 | 93 | 2 | PF02824 | |
| Domain | Glyco_hydro_31 | 5.07e-04 | 7 | 93 | 2 | IPR000322 | |
| Domain | TGS-like | 5.07e-04 | 7 | 93 | 2 | IPR012676 | |
| Domain | tRNA_SAD | 5.07e-04 | 7 | 93 | 2 | SM00863 | |
| Domain | tRNA_SAD | 5.07e-04 | 7 | 93 | 2 | IPR012947 | |
| Domain | Glyco_hydro_31 | 5.07e-04 | 7 | 93 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 5.07e-04 | 7 | 93 | 2 | PS00129 | |
| Domain | tRNA_SAD | 5.07e-04 | 7 | 93 | 2 | PF07973 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 6.74e-04 | 8 | 93 | 2 | IPR018163 | |
| Domain | BEACH_dom | 8.63e-04 | 9 | 93 | 2 | IPR000409 | |
| Domain | BEACH | 8.63e-04 | 9 | 93 | 2 | PS50197 | |
| Domain | Beach | 8.63e-04 | 9 | 93 | 2 | PF02138 | |
| Domain | - | 8.63e-04 | 9 | 93 | 2 | 1.10.1540.10 | |
| Domain | Beach | 8.63e-04 | 9 | 93 | 2 | SM01026 | |
| Domain | HGTP_anticodon | 8.63e-04 | 9 | 93 | 2 | PF03129 | |
| Domain | DAGK_acc | 1.08e-03 | 10 | 93 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.08e-03 | 10 | 93 | 2 | IPR000756 | |
| Domain | DAGKa | 1.08e-03 | 10 | 93 | 2 | SM00045 | |
| Domain | aa-tRNA-synt_IIb | 1.31e-03 | 11 | 93 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 1.31e-03 | 11 | 93 | 2 | PF00587 | |
| Domain | - | 1.31e-03 | 11 | 93 | 2 | 3.40.50.800 | |
| Domain | COS_domain | 1.57e-03 | 12 | 93 | 2 | IPR017903 | |
| Domain | COS | 1.57e-03 | 12 | 93 | 2 | PS51262 | |
| Domain | Beta-grasp_dom | 2.15e-03 | 14 | 93 | 2 | IPR012675 | |
| Domain | - | 2.15e-03 | 14 | 93 | 2 | 3.10.20.30 | |
| Domain | Anticodon-bd | 2.15e-03 | 14 | 93 | 2 | IPR004154 | |
| Domain | DAGKc | 2.15e-03 | 14 | 93 | 2 | SM00046 | |
| Domain | Bbox_C | 2.47e-03 | 15 | 93 | 2 | IPR003649 | |
| Domain | Diacylglycerol_kinase_cat_dom | 2.47e-03 | 15 | 93 | 2 | IPR001206 | |
| Domain | BBC | 2.47e-03 | 15 | 93 | 2 | SM00502 | |
| Domain | DAGK_cat | 2.47e-03 | 15 | 93 | 2 | PF00781 | |
| Domain | DAGK | 2.47e-03 | 15 | 93 | 2 | PS50146 | |
| Domain | - | 2.81e-03 | 16 | 93 | 2 | 3.20.20.100 | |
| Domain | - | 3.05e-03 | 120 | 93 | 4 | 3.40.50.150 | |
| Domain | Gal_mutarotase_SF_dom | 3.18e-03 | 17 | 93 | 2 | IPR011013 | |
| Domain | NAD/diacylglycerol_kinase | 3.18e-03 | 17 | 93 | 2 | IPR016064 | |
| Domain | SAM-dependent_MTases | 3.23e-03 | 122 | 93 | 4 | IPR029063 | |
| Domain | Iontro_rcpt | 3.56e-03 | 18 | 93 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 3.56e-03 | 18 | 93 | 2 | PF10613 | |
| Domain | aa-tRNA-synth_II | 3.56e-03 | 18 | 93 | 2 | IPR006195 | |
| Domain | Iono_rcpt_met | 3.56e-03 | 18 | 93 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.56e-03 | 18 | 93 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.56e-03 | 18 | 93 | 2 | SM00918 | |
| Domain | Lig_chan | 3.56e-03 | 18 | 93 | 2 | PF00060 | |
| Domain | PBPe | 3.56e-03 | 18 | 93 | 2 | SM00079 | |
| Domain | AA_TRNA_LIGASE_II | 3.56e-03 | 18 | 93 | 2 | PS50862 | |
| Domain | LIM | 4.94e-03 | 69 | 93 | 3 | PF00412 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 2.29e-06 | 19 | 72 | 4 | M27449 | |
| Pathway | WP_AFLATOXIN_B1_METABOLISM | 2.53e-06 | 6 | 72 | 3 | MM15846 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 8.59e-06 | 26 | 72 | 4 | MM15190 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 8.61e-06 | 55 | 72 | 5 | M39763 | |
| Pathway | REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD | 2.55e-04 | 5 | 72 | 2 | M27427 | |
| Pubmed | Fam72a enforces error-prone DNA repair during antibody diversification. | 5.68e-11 | 4 | 97 | 4 | 34819671 | |
| Pubmed | Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. | 2.84e-10 | 5 | 97 | 4 | 19755123 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 26206078 | ||
| Pubmed | FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. | 8.49e-10 | 6 | 97 | 4 | 34819670 | |
| Pubmed | 2.99e-09 | 21 | 97 | 5 | 27740716 | ||
| Pubmed | 7.73e-09 | 25 | 97 | 5 | 17307970 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 22863590 | ||
| Pubmed | Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. | 2.10e-08 | 3 | 97 | 3 | 12123834 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 24590062 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 12071861 | ||
| Pubmed | Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. | 2.10e-08 | 3 | 97 | 3 | 16919859 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 39365156 | ||
| Pubmed | The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping. | 2.77e-08 | 12 | 97 | 4 | 10495887 | |
| Pubmed | 3.99e-08 | 13 | 97 | 4 | 8557689 | ||
| Pubmed | 5.57e-08 | 14 | 97 | 4 | 25852085 | ||
| Pubmed | 7.58e-08 | 15 | 97 | 4 | 1741163 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 12879023 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 23033484 | ||
| Pubmed | Migration and synaptogenesis of cone photoreceptors in the developing mouse retina. | 7.30e-07 | 7 | 97 | 3 | 9364238 | |
| Pubmed | SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. | 7.70e-06 | 2 | 97 | 2 | 19176798 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 37059185 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26095046 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26085644 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18524768 | ||
| Pubmed | Role of Prickle1 and Prickle2 in neurite outgrowth in murine neuroblastoma cells. | 7.70e-06 | 2 | 97 | 2 | 22218901 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12525887 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26085088 | ||
| Pubmed | Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. | 7.70e-06 | 2 | 97 | 2 | 18815274 | |
| Pubmed | Mutations in prickle orthologs cause seizures in flies, mice, and humans. | 7.70e-06 | 2 | 97 | 2 | 21276947 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7681585 | ||
| Pubmed | Toll-like receptor 9 trafficking and signaling for type I interferons requires PIKfyve activity. | 7.70e-06 | 2 | 97 | 2 | 25925170 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30038560 | ||
| Pubmed | A threonyl-tRNA synthetase-like protein has tRNA aminoacylation and editing activities. | 7.70e-06 | 2 | 97 | 2 | 29579307 | |
| Pubmed | SV2 mediates entry of tetanus neurotoxin into central neurons. | 7.70e-06 | 2 | 97 | 2 | 21124874 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34613779 | ||
| Pubmed | Calcium dynamics change in degenerating cone photoreceptors. | 7.70e-06 | 2 | 97 | 2 | 27402880 | |
| Pubmed | Diacylglycerol kinase K variants impact hypospadias in a California study population. | 7.70e-06 | 2 | 97 | 2 | 23177175 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28869603 | ||
| Pubmed | Mouse Prickle1 and Prickle2 are expressed in postmitotic neurons and promote neurite outgrowth. | 7.70e-06 | 2 | 97 | 2 | 17868671 | |
| Pubmed | SV2 regulates neurotransmitter release via multiple mechanisms. | 7.70e-06 | 2 | 97 | 2 | 20702688 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12038792 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31710697 | ||
| Pubmed | Synaptic vesicle protein 2 enhances release probability at quiescent synapses. | 7.70e-06 | 2 | 97 | 2 | 16436618 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20042464 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18498711 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22847229 | ||
| Pubmed | Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). | 7.70e-06 | 2 | 97 | 2 | 10611374 | |
| Pubmed | SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. | 7.70e-06 | 2 | 97 | 2 | 10624962 | |
| Pubmed | 9.25e-06 | 47 | 97 | 4 | 33141892 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23617838 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 37172907 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23724117 | ||
| Pubmed | RETINAL DEGENERATION IN THE MOUSE: LOCATION OF THE RD LOCUS IN LINKAGE GROUP XVII. | 2.31e-05 | 3 | 97 | 2 | 14276177 | |
| Pubmed | Mink1 regulates β-catenin-independent Wnt signaling via Prickle phosphorylation. | 2.31e-05 | 3 | 97 | 2 | 22037766 | |
| Pubmed | Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. | 2.31e-05 | 3 | 97 | 2 | 17704206 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 27268253 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23937191 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26015569 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 29812984 | ||
| Pubmed | Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns. | 2.31e-05 | 3 | 97 | 2 | 33588752 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22901752 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12644274 | ||
| Pubmed | A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. | 2.31e-05 | 3 | 97 | 2 | 28090087 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26680738 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18976727 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19252089 | ||
| Pubmed | Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. | 2.31e-05 | 3 | 97 | 2 | 17600127 | |
| Pubmed | Prickle promotes neurite outgrowth via the Dishevelled dependent pathway in C1300 cells. | 2.31e-05 | 3 | 97 | 2 | 19788910 | |
| Pubmed | No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. | 2.31e-05 | 3 | 97 | 2 | 18977120 | |
| Pubmed | Regulatory CD4+Foxp3+ T cells control the severity of anaphylaxis. | 2.31e-05 | 3 | 97 | 2 | 23922690 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16543415 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12687700 | ||
| Pubmed | SV2 modulates the size of the readily releasable pool of secretory vesicles. | 2.31e-05 | 3 | 97 | 2 | 11483953 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28454120 | ||
| Pubmed | Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. | 2.32e-05 | 20 | 97 | 3 | 9828140 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 31825309 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 21697861 | ||
| Pubmed | Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice. | 4.60e-05 | 4 | 97 | 2 | 23894296 | |
| Pubmed | IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut. | 4.60e-05 | 4 | 97 | 2 | 29742432 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 24459426 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 11668586 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15938621 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19758987 | ||
| Pubmed | Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis. | 4.60e-05 | 4 | 97 | 2 | 28459195 | |
| Pubmed | Mast cells enhance T cell activation: Importance of mast cell-derived TNF. | 4.60e-05 | 4 | 97 | 2 | 15840716 | |
| Pubmed | Seizures are regulated by ubiquitin-specific peptidase 9 X-linked (USP9X), a de-ubiquitinase. | 4.60e-05 | 4 | 97 | 2 | 25763846 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 35420656 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 4595403 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 20410110 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 36176272 | ||
| Pubmed | Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. | 4.60e-05 | 4 | 97 | 2 | 16150726 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 21799013 | ||
| Pubmed | Towards complete sets of farnesylated and geranylgeranylated proteins. | 4.60e-05 | 4 | 97 | 2 | 17411337 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 14687666 | ||
| Pubmed | Synaptotagmin 1-triggered lipid signaling facilitates coupling of exo- and endocytosis. | 4.60e-05 | 4 | 97 | 2 | 37738980 | |
| Pubmed | A pair of E3 ubiquitin ligases compete to regulate filopodial dynamics and axon guidance. | 4.60e-05 | 4 | 97 | 2 | 31820781 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 11258696 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 28576980 | ||
| Pubmed | Developmental and spatial expression pattern of syntaxin 13 in the mouse central nervous system. | 7.66e-05 | 5 | 97 | 2 | 12172780 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 17298551 | ||
| Interaction | PDE5A interactions | 2.03e-06 | 20 | 94 | 4 | int:PDE5A | |
| Cytoband | 1p36.13 | 2.34e-04 | 56 | 97 | 3 | 1p36.13 | |
| GeneFamily | Phosphodiesterases | 2.81e-08 | 24 | 69 | 5 | 681 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 2.12e-07 | 4 | 69 | 3 | 1184 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.08e-04 | 9 | 69 | 2 | 1230 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 6.33e-04 | 10 | 69 | 2 | 1178 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.47e-04 | 394 | 69 | 7 | 471 | |
| GeneFamily | Aldo-keto reductases | 1.46e-03 | 15 | 69 | 2 | 399 | |
| GeneFamily | LIM domain containing | 1.48e-03 | 59 | 69 | 3 | 1218 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 2.88e-03 | 21 | 69 | 2 | 680 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN | 6.91e-06 | 198 | 93 | 7 | M6731 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.94e-06 | 182 | 97 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-06 | 187 | 97 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.02e-06 | 60 | 97 | 4 | 64d4de1de20d07c5f2e20b76854311a31718faa4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.02e-06 | 60 | 97 | 4 | b3941f8c3cf2365c5bf79961f62c9c0c7405a67b | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.64e-05 | 160 | 97 | 5 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 165 | 97 | 5 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 169 | 97 | 5 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.53e-05 | 170 | 97 | 5 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 171 | 97 | 5 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 173 | 97 | 5 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 173 | 97 | 5 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-05 | 179 | 97 | 5 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.52e-05 | 179 | 97 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.76e-05 | 181 | 97 | 5 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.89e-05 | 182 | 97 | 5 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 182 | 97 | 5 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 183 | 97 | 5 | f03d87b556a3d50360d4eb6126b3466fe7266677 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-05 | 185 | 97 | 5 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-05 | 185 | 97 | 5 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 5.42e-05 | 186 | 97 | 5 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 5.42e-05 | 186 | 97 | 5 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.56e-05 | 187 | 97 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-05 | 187 | 97 | 5 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-05 | 187 | 97 | 5 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.85e-05 | 189 | 97 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 192 | 97 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 6.30e-05 | 192 | 97 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 193 | 97 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.46e-05 | 193 | 97 | 5 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 6.46e-05 | 193 | 97 | 5 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.61e-05 | 194 | 97 | 5 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-05 | 194 | 97 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 6.78e-05 | 195 | 97 | 5 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 195 | 97 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 6.94e-05 | 196 | 97 | 5 | f7e5a7fad4547e8ab9ab8b140239281832fb4260 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 7.11e-05 | 197 | 97 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 7.11e-05 | 197 | 97 | 5 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.28e-05 | 198 | 97 | 5 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | C_01|World / shred on cell type and cluster | 7.28e-05 | 198 | 97 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 7.28e-05 | 198 | 97 | 5 | 41e4bc7964a4895dd05bc62f0ef632ce9c89e34f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | proximal-Hematologic-Proliferating_NK/T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.28e-05 | 198 | 97 | 5 | 6c894fda309ec3d4bb446f63d5dde4e7f8c4fd89 | |
| ToppCell | proximal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.28e-05 | 198 | 97 | 5 | 2777c5efe84ce3dbbe6175ecc1c987bc816ab74b | |
| ToppCell | proximal-Hematologic-Proliferating_NK/T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.28e-05 | 198 | 97 | 5 | 2e121899f58a5024e26441bd326aac12c37fe6d1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 7.46e-05 | 199 | 97 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.64e-05 | 200 | 97 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | c3511607692e05f44538a376253673dd18f77908 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 1c58860932ed47263a5a537a64f0343201463c21 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-04 | 138 | 97 | 4 | 096c0c8ed396a27d29cca94e2e15099b64129c57 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 139 | 97 | 4 | 408bc31aa5e1c2b379f79198fe8b5411f8d7bd08 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 57 | 97 | 3 | 9614fe2acc6ee039383504f94bbe6d35aac27f25 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 57 | 97 | 3 | 309b3d48bfe215d7b581722c06d444b5b2ef6a30 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 57 | 97 | 3 | 3c55a5598a7ea789500f2fbd35c79d2b97a3fc7d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 143 | 97 | 4 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.77e-04 | 144 | 97 | 4 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 147 | 97 | 4 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 152 | 97 | 4 | 6aad62b5b5ad2f78c6600f37960338d40628a439 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.57e-04 | 154 | 97 | 4 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.66e-04 | 155 | 97 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-04 | 155 | 97 | 4 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 156 | 97 | 4 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.75e-04 | 156 | 97 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.75e-04 | 156 | 97 | 4 | d249747c7108a0edfc72d24c09b0b0e4ed662b40 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 156 | 97 | 4 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.75e-04 | 156 | 97 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 159 | 97 | 4 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.03e-04 | 159 | 97 | 4 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.03e-04 | 159 | 97 | 4 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-04 | 160 | 97 | 4 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 160 | 97 | 4 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-04 | 161 | 97 | 4 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-04 | 162 | 97 | 4 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.32e-04 | 162 | 97 | 4 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-04 | 164 | 97 | 4 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | C_02|World / shred on cell type and cluster | 4.63e-04 | 165 | 97 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.63e-04 | 165 | 97 | 4 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.85e-04 | 167 | 97 | 4 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 167 | 97 | 4 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.85e-04 | 167 | 97 | 4 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 167 | 97 | 4 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-04 | 168 | 97 | 4 | e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.96e-04 | 168 | 97 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-04 | 168 | 97 | 4 | b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.30e-04 | 171 | 97 | 4 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-04 | 172 | 97 | 4 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.42e-04 | 172 | 97 | 4 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-04 | 172 | 97 | 4 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-04 | 172 | 97 | 4 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| Drug | dyphylline | 2.46e-07 | 33 | 95 | 5 | CID000003182 | |
| Drug | glycerol-3-phosphocholine | 6.26e-07 | 172 | 95 | 8 | CID000000823 | |
| Drug | CI-930 | 1.31e-06 | 20 | 95 | 4 | CID003021728 | |
| Drug | AA-2379 | 1.61e-06 | 21 | 95 | 4 | CID000128390 | |
| Drug | HWA 153 | 1.96e-06 | 22 | 95 | 4 | CID000162797 | |
| Drug | griseolic acid | 2.37e-06 | 23 | 95 | 4 | CID000127607 | |
| Drug | atherosperminine | 2.37e-06 | 23 | 95 | 4 | CID000096918 | |
| Drug | desethyl KBT-3022 | 3.96e-06 | 26 | 95 | 4 | CID000127736 | |
| Drug | T-440 | 3.96e-06 | 26 | 95 | 4 | CID000177965 | |
| Drug | Ro 15-2041 | 3.96e-06 | 26 | 95 | 4 | CID000132434 | |
| Drug | P-NE | 7.00e-06 | 169 | 95 | 7 | CID000446755 | |
| Drug | PDEs | 9.23e-06 | 116 | 95 | 6 | CID003036959 | |
| Drug | imidazole-4-carboxamide | 9.35e-06 | 32 | 95 | 4 | CID000152917 | |
| Drug | rolipram | 1.10e-05 | 253 | 95 | 8 | CID000005092 | |
| Drug | piroximone | 1.51e-05 | 12 | 95 | 3 | CID000055263 | |
| Drug | AH 21-132 | 1.69e-05 | 37 | 95 | 4 | CID003035793 | |
| Drug | zaprinast | 2.80e-05 | 141 | 95 | 6 | CID000005722 | |
| Drug | amrinone | 3.10e-05 | 43 | 95 | 4 | CID000003698 | |
| Drug | AC1LD8XI | 3.79e-05 | 16 | 95 | 3 | CID000644287 | |
| Drug | milrinone | 3.97e-05 | 150 | 95 | 6 | CID000004197 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 4.49e-05 | 308 | 95 | 8 | CID000001915 | |
| Drug | benzo(a)pyrene-1,6-quinone | 4.59e-05 | 17 | 95 | 3 | ctd:C030233 | |
| Drug | U754 | 4.59e-05 | 17 | 95 | 3 | CID000062824 | |
| Drug | AC1L19O6 | 4.94e-05 | 156 | 95 | 6 | CID000025750 | |
| Drug | N-formyl-L-aspartate | 5.15e-05 | 3 | 95 | 2 | CID000088052 | |
| Drug | esmolol | 5.49e-05 | 18 | 95 | 3 | CID000059768 | |
| Drug | benzo(a)pyrene-7,8-dione | 7.62e-05 | 20 | 95 | 3 | ctd:C076588 | |
| Drug | olprinone | 7.62e-05 | 20 | 95 | 3 | CID000004593 | |
| Drug | felodipine | 7.71e-05 | 169 | 95 | 6 | CID000003333 | |
| Drug | papaverine | 9.64e-05 | 176 | 95 | 6 | CID000004680 | |
| Drug | Ro-1724 | 9.85e-05 | 110 | 95 | 5 | CID000005087 | |
| Drug | siguazodan | 1.02e-04 | 22 | 95 | 3 | CID000072124 | |
| Drug | cyclopropylurea | 1.03e-04 | 4 | 95 | 2 | CID000272626 | |
| Drug | cyclooctylurea | 1.03e-04 | 4 | 95 | 2 | CID000294524 | |
| Drug | succinic semialdehyde | 1.03e-04 | 4 | 95 | 2 | ctd:C009338 | |
| Drug | Tofisopam | 1.03e-04 | 4 | 95 | 2 | DB08811 | |
| Drug | SureCN243145 | 1.03e-04 | 4 | 95 | 2 | CID011446864 | |
| Drug | 2-carboxybenzaldehyde | 1.17e-04 | 23 | 95 | 3 | CID000008406 | |
| Drug | caffeine | CYP1B1 MGAM PDE2A PDE3A PDE6C PDE6B CACNA2D2 GRID1 GRIK4 PDE5A | 1.19e-04 | 562 | 95 | 10 | CID000002519 |
| Drug | PDE I | 1.34e-04 | 24 | 95 | 3 | CID000198428 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CYP1B1 PDE2A PDE3A PDE6C PDE6B CACNA2D2 ADRB2 AIPL1 HRH1 PDE5A | 1.48e-04 | 577 | 95 | 10 | CID000000295 |
| Drug | cilostamide | 1.48e-04 | 120 | 95 | 5 | CID000002753 | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 2897_UP | |
| Drug | ilmenite | 1.71e-04 | 5 | 95 | 2 | CID000159436 | |
| Drug | T-0156 | 1.71e-04 | 5 | 95 | 2 | CID000005368 | |
| Drug | pyrimidine-2,4-dione | 1.71e-04 | 5 | 95 | 2 | CID000150747 | |
| Drug | 4-chloro-3-nitrobenzaldehyde | 1.71e-04 | 5 | 95 | 2 | CID000085505 | |
| Drug | 8-pCPT-cGMP | 1.78e-04 | 67 | 95 | 4 | CID000123969 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 1.42e-05 | 47 | 92 | 4 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | X-24462 measurement | 2.88e-05 | 3 | 92 | 2 | EFO_0800886 | |
| Disease | amino acid metabolic disorder (implicated_via_orthology) | 5.75e-05 | 4 | 92 | 2 | DOID:9252 (implicated_via_orthology) | |
| Disease | cystic fibrosis (is_implicated_in) | 8.13e-05 | 27 | 92 | 3 | DOID:1485 (is_implicated_in) | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 1.43e-04 | 6 | 92 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.50e-04 | 33 | 92 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.61e-04 | 163 | 92 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Graves' disease (is_implicated_in) | 2.47e-04 | 39 | 92 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | aflatoxin B1 aldehyde reductase member 2 measurement | 2.66e-04 | 8 | 92 | 2 | EFO_0020132 | |
| Disease | executive function measurement, unipolar depression, cognitive function measurement | 5.48e-04 | 51 | 92 | 3 | EFO_0003761, EFO_0008354, EFO_0009332 | |
| Disease | neutrophil count, eosinophil count | 5.53e-04 | 213 | 92 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | Hepatomegaly | 6.48e-04 | 54 | 92 | 3 | C0019209 | |
| Disease | neutrophil count, basophil count | 6.94e-04 | 224 | 92 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | peak expiratory flow | 9.53e-04 | 498 | 92 | 7 | EFO_0009718 | |
| Disease | unipolar depression, cognitive function measurement | 9.83e-04 | 15 | 92 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.16e-03 | 66 | 92 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | granulocyte count | 1.22e-03 | 254 | 92 | 5 | EFO_0007987 | |
| Disease | response to cyclophosphamide | 1.27e-03 | 17 | 92 | 2 | GO_1902518 | |
| Disease | spinal stenosis | 1.27e-03 | 17 | 92 | 2 | EFO_0007490 | |
| Disease | oleoylcarnitine measurement | 1.59e-03 | 19 | 92 | 2 | EFO_0021043 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 1.68e-03 | 75 | 92 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | pancreatic carcinoma | 2.18e-03 | 174 | 92 | 4 | EFO_0002618 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 2.33e-03 | 23 | 92 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | body fat percentage, coronary artery disease | 2.54e-03 | 24 | 92 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.54e-03 | 24 | 92 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | interstitial lung disease (is_marker_for) | 2.75e-03 | 25 | 92 | 2 | DOID:3082 (is_marker_for) | |
| Disease | anogenital venereal wart (is_marker_for) | 2.98e-03 | 26 | 92 | 2 | DOID:11168 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALSVSNMSHHWAGEY | 296 | Q8IZF5 | |
| MHWYRATHQEAINCY | 171 | P07550 | |
| LRWMYHHSQLQGAHG | 296 | O43488 | |
| WHVHTCGLANMFAYH | 116 | Q9NZN9 | |
| HGNEMSGVYLARHWL | 21 | Q96HD9 | |
| AALRWMYHHSQLQGA | 266 | Q8NHP1 | |
| ATLRWMYHHSQLQGA | 266 | O95154 | |
| AYSFPQQHTMQHWAR | 61 | Q9NY47 | |
| ALWEDSSNGQMFHAH | 781 | P26358 | |
| MWAGHQTHHSSEDYN | 141 | Q6ZNB7 | |
| MNYSGWSHRDDFLHG | 806 | Q9UNA0 | |
| WSHRDDFLHGMGYSA | 811 | Q9UNA0 | |
| NWHGVHKNDDRSSYA | 271 | Q008S8 | |
| MDYSLAAALTLHGHW | 91 | O14521 | |
| GYSHWYSSPHQDTMQ | 156 | P56179 | |
| SLTSLVDYWHFNMHD | 841 | Q96MT7 | |
| RESWMLHNSGFRNYN | 716 | Q9UPQ7 | |
| HFYLGSANMDWRSLT | 211 | Q8IV08 | |
| GMHCWYSSYSHRTQH | 326 | Q5KSL6 | |
| GLAWSSHDAESFQMH | 471 | Q12913 | |
| YNQSEAGSHTLQWMH | 106 | P13747 | |
| DHWMQYRLSGSFAHQ | 26 | P55344 | |
| WRNTHAHGSHYNPIM | 751 | Q9H2X6 | |
| GFTFSSYAMHWVRQA | 46 | A0A075B6Q5 | |
| EHYNSHRGLIMYSWD | 146 | P19256 | |
| DWNGDHIHTNFRDMY | 651 | Q14703 | |
| SWHHGDFNYERQATL | 261 | P10721 | |
| CNNRHFWMFHSQAVY | 96 | Q6L9T8 | |
| TGLMQLTWLYLDHNH | 86 | Q86UE6 | |
| YHVSGEFAMLWHGAQ | 276 | P13716 | |
| YSLHGFIMHNNDLTW | 371 | O95671 | |
| WMQLGAFYPFSRNHN | 1571 | O43451 | |
| MEEYHTWQNFGNSHR | 351 | Q5U5R9 | |
| MAHHSLNTFYIWHNN | 1 | Q9Y6C7 | |
| TNSGYSGMWHRAEHA | 276 | Q9UBQ6 | |
| AYHRWNGHTDMIDQD | 481 | Q9UHG3 | |
| HNWMHAFSVSHFCYL | 656 | O00408 | |
| ENHHAAAAWNLFMSR | 866 | Q14432 | |
| AYHNWRHAFNTAQCM | 611 | O76074 | |
| YHNWRHGFNVAQTMF | 556 | P35913 | |
| YHNWRHGFNVGQTMF | 561 | P51160 | |
| HSWEMSEFHNYNLDL | 11 | P26718 | |
| CNNGHFWMFHSQAVY | 96 | Q5TYM5 | |
| MTGSHLSHDSWQYVL | 1 | Q6IE36 | |
| QFNVEHFSGMHNWYA | 166 | Q86XP1 | |
| HFSGMHNWYACSHAR | 171 | Q86XP1 | |
| INHMVNHSWGRQYSH | 286 | Q9P1Z3 | |
| MAAAEHRHSSGLPYW | 236 | E9PIF3 | |
| GRFDYWGNSHQIMHL | 231 | Q8N4S7 | |
| DHAQMTYDGQHWHAT | 261 | Q96MT3 | |
| QGQMTYDGQHWHATE | 266 | Q7Z3G6 | |
| DQGQMAYEGQHWHAS | 321 | O43900 | |
| SSGMEFQDHRYWLRT | 366 | Q9Y2I7 | |
| IEAHGSYFHMAAWGL | 351 | O00144 | |
| DNMSDSFYVTWGARH | 2566 | Q8NCM8 | |
| NRGWMPIHEAAYHNS | 41 | Q9Y575 | |
| GQSHAAVLWMEYHLT | 606 | Q9NVM4 | |
| QDFTWSQHYSGGHTM | 46 | P51161 | |
| HYMPDHWQGNAHRSQ | 446 | Q7Z3C6 | |
| WSHNFTNMLGYTDHQ | 236 | O75390 | |
| CNNRHFWMFHSQAVY | 96 | H0Y354 | |
| HAWMNYTAILFTHAE | 136 | P0DJR0 | |
| SRNHYGWSALMQAAR | 106 | Q68DC2 | |
| DSVHGWTALMQATYH | 356 | Q68DC2 | |
| HFAATHSLEFMWRQT | 321 | P49641 | |
| HTAESYMLQWQRGHL | 296 | Q92636 | |
| RYGHQLHNTSWNGMI | 491 | Q9ULK0 | |
| SMAFGHYSEHWKVQR | 131 | Q16678 | |
| NEHLHMFTIWLGYIN | 446 | P35367 | |
| QWHVAEGLSMDSHLY | 391 | Q16099 | |
| WHMAYHGSNVAAVRR | 1416 | Q96JN8 | |
| CNNGHFWMFHSQAVY | 96 | Q86X60 | |
| FRAMWKLFSSHYNVH | 591 | O14829 | |
| EGIWSYLMHFLFDHS | 306 | Q8NGK6 | |
| EYWQSLEVSHHMVFN | 86 | Q92521 | |
| GHWQHYSENMFTFEI | 466 | A2RTX5 | |
| SGHWQHYSENMFSFE | 386 | P26639 | |
| HGHWVNTMALSTDYA | 286 | Q9NVX2 | |
| NVLNRHHWMYNATSY | 366 | Q10713 | |
| LGAVEFHYFQRMSSW | 356 | Q9NUP7 | |
| WASMHVSDHSGFHYR | 226 | Q7Z6K3 | |
| SMGTNYHFHSWRVFV | 266 | Q7L1I2 | |
| MTGINYLDTHSNFWR | 226 | Q96NG3 | |
| WVHDAYSQAHLTLMA | 126 | Q8IY81 | |
| FIYESWLIHHGTQMS | 71 | Q8N8Z3 | |
| YSVHNGNFQTWMGAH | 316 | Q01113 | |
| SFQMGSAYQFHSWRV | 321 | Q7L0J3 | |
| ENHYHTFLLWAMRGI | 221 | Q8TCY9 | |
| EPWLHSMYHGAAFQL | 161 | P01374 | |
| QMRWFLRETGHYHSF | 141 | Q6ZRR5 | |
| YVDNNRSWFMHCNSH | 691 | Q6ZTA4 | |
| FRTNFRLWSHFQSHM | 946 | Q9ULJ3 | |
| HAGLYMWHLVGHQRN | 111 | Q8WVN6 | |
| GHMWAEGDLYLHFFQ | 611 | Q9NR96 | |
| YHSSQWMVAGNTDHL | 156 | Q9Y458 | |
| WFMHNNSHTNRTEGG | 626 | Q9C026 | |
| RHDAAEITVMHYWFG | 836 | Q5H8A4 | |
| DFHQSMAQWLAYSRL | 346 | Q70J99 | |
| DWVHGRISNFHYLMQ | 351 | Q562E7 | |
| AAAHWYGGAEMRTQH | 181 | Q6NSJ0 |